Pyxis Oncology annual total assets
2020
2021
2022
2023
2024
2025
Pyxis Oncology Total Assets Growth & History (PYXS)
Pyxis Oncology's total assets was $91.5M for fiscal 2025.
View full Pyxis Oncology company overviewPyxis Oncology annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $91.5M | −$65.7M | −41.77% |
| 2024 | 2024-12-31 | $157.2M | −$16.5M | −9.52% |
| 2023 | 2023-12-31 | $173.7M | −$37.7M | −17.81% |
| 2022 | 2022-12-31 | $211.4M | −$68.6M | −24.51% |
| 2021 | 2021-12-31 | $280.0M | $269.9M | +2658.56% |
| 2020 | 2020-12-31 | $10.2M | — | — |
Pyxis Oncology quarterly total assets
Q4.20
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $54.9M | −$68.3M | −55.43% |
| Q1 2026 | 2026-03-31 | $64.3M | −$71.6M | −52.67% |
| Q4 2025 | 2025-12-31 | $91.5M | −$65.7M | −41.77% |
| Q3 2025 | 2025-09-30 | $105.6M | −$89.7M | −45.93% |
| Q2 2025 | 2025-06-30 | $123.2M | −$85.2M | −40.87% |
| Q1 2025 | 2025-03-31 | $135.9M | −$84.4M | −38.30% |
| Q4 2024 | 2024-12-31 | $157.2M | −$16.5M | −9.52% |
| Q3 2024 | 2024-09-30 | $195.3M | $8.6M | +4.62% |
| Q2 2024 | 2024-06-30 | $208.4M | $33.2M | +18.92% |
| Q1 2024 | 2024-03-31 | $220.2M | $37.4M | +20.47% |
| Q4 2023 | 2023-12-31 | $173.7M | −$37.7M | −17.81% |
| Q3 2023 | 2023-09-30 | $186.7M | −$37.2M | −16.62% |
| Q2 2023 | 2023-06-30 | $175.2M | −$67.3M | −27.76% |
| Q1 2023 | 2023-03-31 | $182.8M | −$69.9M | −27.66% |
| Q4 2022 | 2022-12-31 | $211.4M | −$68.6M | −24.51% |
| Q3 2022 | 2022-09-30 | $223.9M | $84.4M | +60.51% |
| Q2 2022 | 2022-06-30 | $242.6M | — | — |
| Q1 2022 | 2022-03-31 | $252.7M | — | — |
| Q4 2021 | 2021-12-31 | $280.0M | $269.9M | +2658.56% |
| Q3 2021 | 2021-09-30 | $139.5M | — | — |
| Q4 2020 | 2020-12-31 | $10.2M | — | — |
Pyxis Oncology total assets trends
Over the last five fiscal years, Pyxis Oncology's total assets increased from $10.2M to $91.5M, a change of $81.4M. The latest reported quarter, Q2 2026, shows $54.9M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Pyxis Oncology source filings ↗